Patient Counseling Section Of Labeling Should Be Limited, FDA Advises
This article was originally published in The Pink Sheet Daily
Executive Summary
Only the most important, not necessarily the most common, side effects should be included in the section denoting what a health care provider should tell a patient, FDA’s draft guidance says; section was mandated under 2006 physician labeling rule.